NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

Company

We are a vibrant young company committed to applying a powerful new genomic technology across disciplines to improve human health and accelerate scientific discovery. Our mission is to develop and deliver the unprecedented accuracy of duplex sequencing technology to applications in clinical medicine and life sciences where it can do the greatest good for the greatest number of people. Our approach is multifaceted and encompasses internal development projects, external collaborations and empowering of partner organizations. Our operation is strongly rooted in academic principles of responsible citizenship within the broader scientific community, yet executed with the nimbleness of a startup, such that research can be rapidly translated into products that benefit people.